Drugs / CMVIG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00784979 Comparator | Jan 2002 → Dec 2010 | end stage renal failure | Tampa General Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00784979 ↗ |
| Modality | Protein / enzyme biologic | “Cytomegalovirus Immune Globulin - Intravenous” NCT00784979 ↗ |
| Route | Intravenous | “400mg/kg IV” NCT00784979 ↗ |